August 2026 FDA Recall Mycophenolate Mofetil by Mylan Pharmaceuticals Inc
D-0830-2026 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc on August 26, 2026 for the product Mycophenolate Mofetil. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0830-2026

Reason for Recall
Failed Dissolution Specifications
Initiated
08-26-2026
Reported
09-09-2026
Quantity
11,336 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mylan Pharmaceuticals Inc
Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-81. Vial Label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, Single Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-00.

Batch or Lot Expiration Information

Lot# Lot: 3242616, Exp. April 2027; 8220216, Exp. Nov 2027